An analysis of the interactions between individual comorbidities and their treatments-implications for guidelines and polypharmacy

Journal of the American Medical Directors Association

Volumn 11, Issue 7, 2010, Pages 475-484

  Fitzgerald, Stephen P ^a   Bean, Nigel G ^b  

^a ROYAL ADELAIDE HOSPITAL   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AGING; ARTICLE; COMORBIDITY; HEART ATRIUM FIBRILLATION; HUMAN; INTESTINE CANCER; MATHEMATICAL ANALYSIS; MATHEMATICAL MODEL; POLYPHARMACY; PRACTICE GUIDELINE; RISK REDUCTION; VALIDATION PROCESS;

EID: 77956266237     PISSN: 15258610     EISSN: 15389375     Source Type: Journal    
DOI: 10.1016/j.jamda.2010.05.008     Document Type: Article

References (33)

1. Hilmer N.H. The dilemma of polypharmacy. Aust Prescr 2009, 31:2-3.
2. Tonkin A.M., Boyden A.N., Colagiuri S. Maximising the effectiveness and cost-effectiveness of cardiovascular disease prevention in the general population. Med J Aust 2009, 191:300-302.
3. Seeman E., Kotowicz M.A., Nash P.T., Sambrook P.N. Inappropriate prescribing for osteoporosis. Med J Aust 2009, 191:355-356.
4. Webster J.R., Heeley E.L., Peiris D.P., et al. Gaps in cardiovascular disease risk management in Australian general practice. Med J Aust 2009, 191:324-329.
5. Medi C., Hankey G.J., Freedman S.B. Atrial fibrillation. Med J Aust 2007, 186:197-202.
6. Fitzgerald S.P., Phillipov G. Patient attitudes to commonly promoted medical interventions. Med J Aust 2000, 172:9-12.
7. Boyd C.M., Darer J., Boult C., et al. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases. JAMA 2005, 294:716-724.
8. Guidelines for improving the care of the older person with diabetes mellitus. J Am Geriatr Soc 2003, 51:S265-S280. California Healthcare Foundation/American Geriatrics Society Panel on Improving Care for Elders with Diabetes.
9. Durso S.C. Using clinical guidelines designed for older adults with diabetes mellitus and complex health status. JAMA 2006, 295:1935-1940.
10. Jassal S.V., Krahn M.D., Naglie G., et al. Kidney transplantation in the elderly: a decision analysis. J Am Soc Nephrol 2003, 14:187-196.
11. Sommers B.D., Beard C.J., D'Amico A.V., et al. Decision analysis using individual patient preferences to determine optimal treatment for localized prostate cancer. Cancer 2007, 110:2210-2217.
12. Montgomery A.A., Harding J., Fahey T. Shared decision making in hypertension: The impact of patient preferences on treatment choice. Family Practice 2001, 18:309-313.
13. Nagaki T., Sato K., Yoshida T., Yoshimoto Y. Benefit of carotid endarterectomy for symptomatic and asymptomatic severe carotid artery stenosis: A Markov model based on data from randomized controlled trials. J Neurosurg 2009, 111:970-977.
14. Elwyn G., Edwards A., Eccles M., Rovner D. Decision analysis in patient care. Lancet 2001, 358:571-574.
15. Nordin C.B.E., Horowitz M., Chatterton B.E. Inappropriate prescribing for osteoporosis. Med J Aust 2009, 190:519-520.
16. Dimmitt S.B., Stampfer H.G. Low drug doses may improve outcomes in chronic Disease. Med J Aust 2009, 191:511-513.
17. Gialamas A., Yelland L.N., Ryan P., et al. Does point-of-care testing lead to the same or better adherence to medication? A randomised controlled trial: the PoCT in General Practice Trial. Med J Aust 2009, 191:487-491.
18. Fitzgerald S.P. The overall benefits risks and costs of multiple interventions may be less favourable than the sum of the benefits risks and costs of those individual interventions. Medical Hypotheses 2007, 69:970-973.
19. Crimmims E.M., Hayward M.D., Hagedorn A., et al. Change in disability-free life expectancy for Americans 70 years old and older. Demography 2009, 46:627-646.
20. Beckett N.S., Peters R., Fletcher A.E., et al. Treatment of hypertension in patients 80 years of age or older. N Engl J Med 2008, 358:1887-1898.
21. Musini V.M., Tejani A.M., Bassett K., Wright J.M. Pharmacotherapy for hypertension in the elderly. Cochrane Database Syst Rev 2009, 7. CD000028.
22. Shepherd J., Blauw G.J., Murphy M.B., et al. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): A randomised controlled trial. Lancet 2002, 360:1623-1630.
23. Cutler D.M., Rosen A.B., Vigan S. The value of medical spending in the United States, 1960-2000. N Engl J Med 2006, 355:920-927.
24. Haughnessy A.F., Slawson D.C., Barnett B.L. What happened to the valid POEMs? A survey of review articles on the treatment of type 2 diabetes. BMJ 2003, 327:266.
25. Deplanque D., Leys D., Parnetti L., et al. Stroke prevention and atrial fibrillation: Reasons leading to an inappropriate management. Main results of the SAFE II study. Br J Clin Pharmacol 2004, 57:798-806.
26. Shah A.N., Vail T.P., Taylor D., Pietrobon R. Comorbid illness affects hospital costs related to hip arthroplasty: Quantification of health status and implications for fair reimbursement and surgeon comparisons. J Arthroplasty 2004, 19:700-705.
27. Flaherty J.H., Morley J.E., Murphy D.J., Wasserman M.R. The development of outpatient clinical glidepaths. J Am Geriatr Soc 2002, 50:1886-1901.
28. Winstein M.C., Skinner J.A. Comparative effectiveness and health care spending- Implications for reform. N Engl J Med 2010, 362:460-465.
29. Sanders G.D., Hlatky M.A., Owens D.K. Cost-effectiveness of implantable cardioverter-defibrillators. N Engl J Med 2005, 353:1471-1480.
30. Hylek E.M., Magnani J.W. Methodological considerations for interpretation of rates of major haemorrhage in studies of anticoagulant therapy for atrial fibrillation. Europace 2008, 10:3-5.
31. Hylek E.M., Evans-Molina C., Shea C., et al. Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation. Circulation 2007, 115:2689-2696.
32. Wyse D.G. Bleeding while starting anticoagulation for thromboembolism prophylaxis in elderly patients with atrial fibrillation from bad to worse. Circulation 2007, 15:2684-2686.
33. Henriksson K.M., Farahmand B., Johansson S., et al. Survival after stroke-The impact of CHADS2 score and atrial fibrillation. Int J Cardiol 2010, 141:18-23.